Loading clinical trials...
Loading clinical trials...
Background: Transcatheter aortic valve replacement (TAVR) is a non-surgical alternative to standard surgical aortic valve replacement. Not all patients are eligible for TAVR using standard access thr...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
NCT06638268 · Aortic Stenosis, Cardiogenic Shock
NCT07469371 · Severe Aortic Stenosis
NCT07197736 · Valve Disease, Aortic, Mitral Regurgitation (MR), and more
NCT07278310 · Symptomatic Severe Native Aortic Stenosis, Aortic Stenosis
NCT06777368 · Aortic Stenosis
MedStar Washington Hospital Center
Washington D.C., District of Columbia
Emory University
Atlanta, Georgia
Henry Ford Hospital
Detroit, Michigan
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions